Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis.
Eker
A
A
Saka
E
E
Dalmau
J
J
Kurne
A
A
Bilen
C
C
Ozen
H
H
Ertoy
D
D
Oguz
K K
KK
Elibol
B
B
D000328:Adult; D000679:Amygdala / Q000276:immunology / Q000473:pathology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D004660:Encephalitis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010257:Paraneoplastic Syndromes / Q000473:pathology / Q000628:therapy; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D018239:Seminoma / Q000150:complications* / Q000473:pathology*; D013724:Teratoma / Q000473:pathology*; D013736:Testicular Neoplasms / Q000473:pathology*
D000893:Anti-Inflammatory Agents; D016194:Receptors, N-Methyl-D-Aspartate; D008775:Methylprednisolone